annb0t
Top 20
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) announced a strategic collaboration with CSL Seqirus, a unit of CSL Limited (OTC: CSLLY) Under the terms of the agreement, Arcturus will provide CSL Seqirus with a license to their self-amplifying mRNA technology to support the research, development, manufacture, and commercialization of vaccines for SARS-CoV-2 (COVID-19), influenza, pandemic-preparedness, as well as three other globally prevalent respiratory infectious diseases. The collaboratio...
>>> Read more: Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
>>> Read more: Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
